CYNTHIA P ROEVER

Allopathic & Osteopathic Physicians|Internal Medicine PALM HARBOR, FL NPI 1295976702

General Payments — all program years on this page

$935.34

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $366.61 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $366.6121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $107.467
2019 $307.0118
2020 $37.663
2023 $116.606
2024 $366.6121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086147415 Bayer Healthcare Pharmaceuticals Inc. $20.39 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334615 Novartis Pharmaceuticals Corporation $13.97 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334633 Novartis Pharmaceuticals Corporation $13.19 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096704325 Novo Nordisk Inc $17.21 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104313518 AstraZeneca Pharmaceuticals LP $18.04 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104351040 AstraZeneca Pharmaceuticals LP $15.53 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105966378 ABBVIE INC. $14.57 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105966380 ABBVIE INC. $18.70 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105966382 ABBVIE INC. $13.35 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105966384 ABBVIE INC. $16.88 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105966386 ABBVIE INC. $23.74 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114859363 Exact Sciences Corporation $17.41 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117367493 Amgen Inc. $20.01 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117367495 Amgen Inc. $18.62 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117367497 Amgen Inc. $17.10 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117367499 Amgen Inc. $18.96 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126635302 Acella Pharmaceuticals, LLC $13.70 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132040403 PFIZER INC. $22.79 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141590692 Merck Sharp & Dohme LLC $19.73 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148910992 Sumitomo Pharma America, Inc. $15.12 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153486227 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.60 08/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.